이야기
2005년 3월 1일
GlaxoSmithKline, AstraZeneca, Merck, Pfizer & other firms join UK govt. in committing to increased access to essential medicines for poorest countries, including via differential pricing
모든 태그 보기
모든 태그 보기
Abbott Laboratories
AstraZeneca
Amgen
Bristol-Myers Squibb
Chiron
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Merck
Merck Sharp & Dohme (part of Merck)
Novartis
Pfizer
Procter & Gamble
Roche
Ranbaxy Laboratories
Schering-Plough
Shire
Tibotec (part of Johnson & Johnson)
Wyeth (part of Pfizer)
Janssen Pharmaceutica (part of Johnson & Johnson)